MLN-8054 | Interleukin Related interleukin-related.com

Product Name :
MLN-8054

Search keywords :
MLN8054

drugId :
null

Target Vo:
Serine/threonine-protein kinase Aurora-A

Target Vo Short Name :
AURKA

Moa_Name:
Serine/threonine-protein kinase Aurora-A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Urinary Bladder Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
VEGF Receptor 1 Rabbit mAb site
GFAP Mouse mAb site
Phospho-MEK1 (Ser298) Antibody: Phospho-MEK1 (Ser298) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to Phospho-MEK1 (Ser298). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts